STABILITECH
Stabilitech is a privately held company focused on stabilisation of sensitive biological molecules, such as vaccines and biopharmaceuticals. The company was founded by Dr Jeff Drew, and started research operations in 2004. Stabilitech is based at the London Bioscience Innovation Centre, London UK. Stabilitech's goal is to improve the stability of vaccines and biopharmaceuticals using their proprietary formulation technology. Stabilitech's technology permits the long-term stabilisation of a wide ... range of thermally sensitive viruses, vaccines and biopharmaceuticals. Excipient compositions contain only chemical ingredients already used in clinical settings, approved injectables or on the Generally Regarded As Safe (GRAS) list. Their business model is to establish partnerships with major pharmaceutical and biotechnology companies, as well as with global health organisations, to commercialise their technology.
STABILITECH
Industry:
Biotechnology Commercial Pharmaceutical
Founded:
2002-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.stabilitech.com
Total Employee:
11+
Status:
Active
Contact:
44 2075 946146
Email Addresses:
[email protected]
Total Funding:
11.63 M USD
Technology used in webpage:
SPF Domain Not Resolving Apache Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS GoDaddy DNS Google Maps API Ubuntu
Official Site Inspections
http://www.stabilitech.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago